Back to Agenda
Session 1: Enhanced Dialogue Learnings and Regulatory Agility in Times of Crisis
Session Chair(s)
Susanne Ausborn, PhD
Global Head International Regulatory Policy
Roche, Switzerland
Sylvie Meillerais, MSc
Director Global CMC Policy
MSD Belgium, Belgium
This session will gather various Stakeholders perspectives in times of crisis, as we are currently facing with the COVID-19 pandemic, and which has generated innovative ways of working, and communicating.
Speaker(s)
Panel Discussion and Q&A, with the participation of:
Fergus Sweeney, PhD
European Medicines Agency, Netherlands
Head of Clinical Studies and Manufacturing Task Force
Panel Discussion and Q&A, with the participation of:
Diane Wilkinson, PhD, RPh
AstraZeneca, United Kingdom
Executive Director, Global CMC Regulatory Affairs
Panel Discussion and Q&A, with the participation of:
Janis Bernat, MSc
IFPMA, Switzerland
Director, Scientific and Regulatory Affairs
Have an account?